2.47

7.39% 0.17

Tuhura Biosciences Inc (HURA)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$2.30

Aprire:

$2.29

Volume 24 ore:

317.09K

Relative Volume:

0.65

Capitalizzazione di mercato:

$157.30M

Reddito:

Utile/perdita netta:

$-30.92M

Rapporto P/E:

-4.0969

EPS:

-0.6029

Flusso di cassa netto:

$-27.39M

1 W Prestazione:

+15.96%

1M Prestazione:

+3.78%

6M Prestazione:

+85.71%

1 anno Prestazione:

-10.51%

Intervallo 1D:

$2.22

$2.49

Intervallo di 1 settimana:

$2.115

$2.58

Portata 52W:

$0.41

$3.43

Tuhura Biosciences Inc Stock (HURA) Company Profile

Nome

Tuhura Biosciences Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

813-875-6600

Indirizzo

10500 UNIVERSITY CENTER DR., TAMPA

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-11

Ultimi documenti SEC

HURA's Discussions on Twitter

Compare HURA vs VRTX, REGN, ARGX, RVMD, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HURA Tuhura Biosciences Inc	2.47	149.02M	0	-30.92M	-27.39M	-0.6029
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-27	Iniziato	Citizens	Mkt Outperform
2025-03-03	Iniziato	H.C. Wainwright	Buy
2024-12-19	Iniziato	Rodman & Renshaw	Buy
2024-11-05	Iniziato	Maxim Group	Buy

Tuhura Biosciences Inc Borsa (HURA) Ultime notizie

Aug 14, 2026

TuHURA Biosciences (NASDAQ:HURA) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Aug 14, 2026

TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord - MarketBeat

Aug 14, 2026

TuHURA Biosciences, Inc.Common Stock (HURA) Stock Price, News, Quote & History - FinancialContent

Aug 14, 2026

TuHURA Biosciences Q2 Results: EPS beats estimate, losses narrow 33% YoY - scanx.trade

Aug 14, 2026

TuHURA Secures $50M Credit Facility Extending Cash Runway into 2028 - Minichart

Aug 14, 2026

Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update - TradingView

Aug 14, 2026

Form 8K TuHURA Biosciences Inc For: 14 August By Investing.com - Investing.com Canada

Aug 14, 2026

TuHURA Reports $1.0 Million Cash and Advances TBS-2025 AML Program - quiverquant.com

Aug 14, 2026

TuHURA Bios reports Q2 2026: $1.0M cash, R&D $6.6M, $50M credit facility extends runway - TradingView

Aug 14, 2026

TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - PR Newswire

Aug 14, 2026

Aug 13, 2026

TuHURA Biosciences Expands Use of Revolving Credit Facility - TipRanks

Aug 13, 2026

Aug 12, 2026

TuHURA at canaccord growth conference: late-stage push gains traction By Investing.com - Investing.com Nigeria

Aug 12, 2026

TuHURA at canaccord growth conference: late-stage push gains traction - Investing.com

Aug 12, 2026

Aug 09, 2026

Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView

Aug 09, 2026

Aug 07, 2026

HURA Q2'26 Earnings: revenue estimate is 0 USD - TradingView

Aug 07, 2026

Aug 06, 2026

TuHURA Biosciences (HURA) Expected to Release Quarterly Earnings on Thursday - MarketBeat

Aug 06, 2026

Jul 28, 2026

TuHURA Biosciences (HURA) Dips 5.9% as Stock Tests Key Support Near $2.00Ichimoku TK Cross - dars.gov.et

Jul 28, 2026

Jul 27, 2026